ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,109
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Results of NEMO: a phase III trial of binimetinib vs dacarbazine in NRAS mutant cutaneous melanoma
Author(s):
R Dummer
,
D Schadendorf
,
PA Ascierto
,
San Martin A Fernández
,
C Dutriaux
,
M Maio
Publication date:
2016
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Scientific Ocean Drilling Expedition Research Results
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,109
Binimetinib in heavily pretreated patients with NRAS ‐mutant melanoma with brain metastases
Authors:
S.M. Goldinger
,
A. Valeska Matter
,
U Urner-Bloch
…
Overall Survival and Biomarker Results from a Phase 2 Study of Mek1/2 Inhibitor Binimetinib (Mek162) in Patients with Advanced Nras-Mutant Melanoma
Authors:
C. Van Herpen
,
S.S. Agarwala
,
A Hauschild
…
A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST).
Authors:
Ping Chi
,
Li-Xuan Qin
,
Ciara Marie Kelly
…
See all similar
Cited by
1
Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients
Authors:
Arthur Frankel
,
Ugur Eskiocak
,
Jennifer G. Gill
…
See all cited by